# Usio, Inc.: overview

USIO · Nasdaq · CIK 1088034 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usio.md) · [Financials](/companies/usio/financials.md) · [Filings](/companies/usio/filings.md) · [Insiders](/companies/usio/insiders.md)

Latest reported revenue: [$23.7m](/filings/0001437749-26-027300.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-027300).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.3](/filings/0001437749-25-034425.md) | [20.6 d](/filings/0001437749-26-008833.md) | [22.0](/filings/0001437749-26-016710.md) | [20.0](/filings/0001437749-26-027300.md) | [21.2](/filings/0001437749-25-034425.md) | [22.2 d](/filings/0001437749-26-008833.md) | [25.5](/filings/0001437749-26-016710.md) | [23.7](/filings/0001437749-26-027300.md) |
| Gross margin | % | [23.0%](/filings/0001437749-25-034425.md) | [24.6% d](/filings/0001437749-26-008833.md) | [21.9%](/filings/0001437749-26-016710.md) | [25.8%](/filings/0001437749-26-027300.md) | [23.0%](/filings/0001437749-25-034425.md) | [21.9% d](/filings/0001437749-26-008833.md) | [20.2%](/filings/0001437749-26-016710.md) | [24.2%](/filings/0001437749-26-027300.md) |
| Operating margin | % | [(1.8%)](/filings/0001437749-25-034425.md) | [(2.9%) d](/filings/0001437749-26-008833.md) | [(1.1%)](/filings/0001437749-26-016710.md) | [(2.0%)](/filings/0001437749-26-027300.md) | [(2.2%)](/filings/0001437749-25-034425.md) | [(5.7%) d](/filings/0001437749-26-008833.md) | [0.9%](/filings/0001437749-26-016710.md) | [1.6%](/filings/0001437749-26-027300.md) |
| Net margin | % | [13.4%](/filings/0001437749-25-034425.md) | [3.1% d](/filings/0001437749-26-008833.md) | [(1.1%)](/filings/0001437749-26-027300.md) | [(1.8%)](/filings/0001437749-26-027300.md) | [(2.0%)](/filings/0001437749-25-034425.md) | [(6.7%) d](/filings/0001437749-26-008833.md) | [0.5%](/filings/0001437749-26-027300.md) | [1.2%](/filings/0001437749-26-027300.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001437749-25-034425.md) | not reported | [(0.01)](/filings/0001437749-26-016710.md) | [(0.01)](/filings/0001437749-26-027300.md) | [(0.02)](/filings/0001437749-25-034425.md) | not reported | [0.00](/filings/0001437749-26-016710.md) | [0.01](/filings/0001437749-26-027300.md) |
| Free cash flow | $m | [1.4 d](/filings/0001437749-25-034425.md) | [0.9 d](/filings/0001437749-26-008833.md) | [1.4](/filings/0001437749-26-016710.md) | [(0.3) d](/filings/0001437749-26-027300.md) | [0.1 d](/filings/0001437749-25-034425.md) | [(0.0) d](/filings/0001437749-26-008833.md) | [0.5](/filings/0001437749-26-016710.md) | [(0.8) d](/filings/0001437749-26-027300.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [61.9](/filings/0001437749-23-005794.md) | [69.4](/filings/0001437749-24-009583.md) | [84.1](/filings/0001437749-25-009368.md) | [82.9](/filings/0001437749-26-008833.md) | [85.4](/filings/0001437749-26-008833.md) |
| Gross margin | % | [25.2%](/filings/0001437749-23-005794.md) | [21.0%](/filings/0001437749-24-009583.md) | [23.9%](/filings/0001437749-25-009368.md) | [23.7%](/filings/0001437749-26-008833.md) | [23.1%](/filings/0001437749-26-008833.md) |
| Operating margin | % | [(0.3%)](/filings/0001437749-23-005794.md) | [(7.5%)](/filings/0001437749-24-009583.md) | [(0.5%)](/filings/0001437749-25-009368.md) | [(1.8%)](/filings/0001437749-26-008833.md) | [(2.8%)](/filings/0001437749-26-008833.md) |
| Net margin | % | [(0.5%)](/filings/0001437749-23-005794.md) | [(7.9%)](/filings/0001437749-24-009583.md) | [(0.6%)](/filings/0001437749-25-009368.md) | [4.0%](/filings/0001437749-26-008833.md) | [(2.9%)](/filings/0001437749-26-008833.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001437749-23-005794.md) | [(0.27)](/filings/0001437749-24-009583.md) | [(0.02)](/filings/0001437749-25-009368.md) | [0.12](/filings/0001437749-26-008833.md) | [(0.09)](/filings/0001437749-26-008833.md) |
| Free cash flow | $m | [28.5](/filings/0001437749-23-005794.md) | [(17.8)](/filings/0001437749-24-009583.md) | [2.7](/filings/0001437749-25-009368.md) | [2.7](/filings/0001437749-26-008833.md) | [1.1](/filings/0001437749-26-008833.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/usio/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WHITTIER TRUST CO](/funds/1137881.md) | 2026-06-30 | $6.4m | 2,713,852 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.3m | 917,455 |  | Added +15,296 |
| [PERKINS CAPITAL MANAGEMENT INC](/funds/884300.md) | 2026-06-30 | $1.7m | 700,371 |  | Reduced −1,561 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.1m | 437,241 |  | Added +36,500 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $457.7k | 184,503 |  | Added +65,386 |
| [North Star Investment Management Corp.](/funds/1342857.md) | 2026-06-30 | $446.4k | 180,000 |  | Unchanged |
| [Stonebridge Wealth Management, LLC](/funds/2082460.md) | 2026-06-30 | $439.2k | 177,084 |  | New +177,084 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $277.2k | 111,768 |  | Added +19,778 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $260.8k | 105,174 |  | Added +784 |
| [Rothschild Wealth LLC](/funds/1811345.md) | 2026-06-30 | $197.7k | 79,700 |  | Reduced −6,000 |

## Recent filings

[All 919 filings](/companies/usio/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:46 ET | [8-K](/filings/0001437749-26-032944.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-032944 |
| 2026-08-12 | 20:00 ET | [10-Q](/filings/0001437749-26-027300.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027300 |
| 2026-08-12 | 20:00 ET | [8-K](/filings/0001437749-26-027301.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027301 |
| 2026-06-17 | 20:01 ET | [8-K](/filings/0001437749-26-020962.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-020962 |
| 2026-06-16 | 20:01 ET | [8-K/A](/filings/0001437749-26-020790.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020790 |
| 2026-06-10 | 20:28 ET | [8-K](/filings/0001437749-26-020174.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020174 |
| 2026-05-13 | 20:02 ET | [8-K](/filings/0001437749-26-016711.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016711 |
| 2026-05-13 | 20:02 ET | [10-Q](/filings/0001437749-26-016710.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016710 |
| 2026-04-29 | 20:01 ET | [DEF 14A](/filings/0001437749-26-013853.md) | Proxy statement, period 2026-06-09 | 0001437749-26-013853 |
| 2026-03-18 | 20:01 ET | [8-K](/filings/0001437749-26-008836.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-008836 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-008833.md), filed Mar 18, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/13b2d3fd-3aad-445c-b5ba-409397fbe6a9)

## About the filer

- CIK: 1088034
- Tickers: USIO
- Exchange: Nasdaq
- SIC code: 6099 Functions Related To Depository Banking, NEC
- State of incorporation: NV
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.
